Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | Osteoporosis | Research

The beneficial effects of simultaneous supplementation of Lactobacillus reuteri and calcium fluoride nanoparticles on ovariectomy-induced osteoporosis

Authors: Dibachehr Rahmani, Bahareh Faal, Hakimeh Zali, Saeed Hesami Tackallou, Zahra Niknam

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Background

The development of new strategies to inhibit and/or treat osteoporosis as a chronic systemic disease is one of the most crucial topics. The present study aimed to investigate the simultaneous effects of calcium fluoride nanoparticles (CaF2 NPs) and lactobacillus reuteri ATCC PTA 6475 (L. reuteri) against osteoporosis in an ovariectomized rat model (OVX).

Methods

In this study, 18 matured Wistar female rats were randomly assigned into 6 groups, including control, OVX, sham, OVX + L. reuteri, OVX + CaF2 NPs, and OVX + L. reuteri + CaF2 NPs. We used OVX rats to simulate post-menopausal osteoporosis, and the treatments were begun two weeks before OVX and continued for four weeks. All groups’ blood samples were collected, and serum biomarkers (estrogen, calcium, vitamin D3, and alkaline phosphatase (ALP)) were measured. The tibia and Femur lengths of all groups were measured. Histopathological slides of tibia, kidney, and liver tissues were analyzed using the Hematoxylin and Eosin staining method.

Results

Our results revealed that dietary supplementation of L. reuteri and CaF2 NPs in low doses for 6 weeks did not show adverse effects in kidney and liver tissues. The tibial and femoral lengths of OVX rats as well as the population of osteoblasts and osteocytes and newly generated osteoid in the tibia remarkably increased in the combination therapy group. Moreover, there was a significant increase in serum estrogen levels and a significant decrease in serum calcium and alkaline phosphatase levels in combination treatment groups compared to the OVX groups not receiving the diet.

Conclusions

Our results suggest the favorable effects of the simultaneous supplementation of L. reuteri and CaF2 NP to reduce post-menopausal bone loss.

Graphical abstract

Literature
1.
Quach D, Parameswaran N, McCabe L, Britton RA. Characterizing how probiotic Lactobacillus reuteri 6475 and lactobacillic acid mediate suppression of osteoclast differentiation. Bone Rep. 2019;11:100227.PubMedPubMedCentralCrossRef
2.
Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21(2):115–37.PubMed
3.
Sözen T, Özışık L, Başaran NÇ. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46.PubMedCrossRef
4.
Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010;31(3):266–300.PubMedPubMedCentralCrossRef
5.
Tonk CH, Shoushrah SH, Babczyk P, Khaldi-Hansen E, Schulze M, Herten M, et al. Therapeutic treatments for osteoporosis—which combination of Pills is the best among the bad? Int J Mol Sci. 2022;23(3):1393.PubMedPubMedCentralCrossRef
6.
Niknam Z, Zali H, Mansouri V, Tavirani MR, Omidi M. Morphological and molecular analysis of osteoblasts differentiated from mesenchymal stem cells in polycaprolactone/magnesium oxide/graphene oxide scaffold. Int J Organ Transplantation Med. 2019;10(4):171.
7.
Niknam Z, Golchin A, Rezaei–Tavirani M, Ranjbarvan P, Zali H, Omidi M, et al. Osteogenic differentiation potential of adipose-derived mesenchymal stem cells cultured on magnesium oxide/polycaprolactone nanofibrous scaffolds for improving bone tissue reconstruction. Adv Pharm Bull. 2020;12(1):142–54.PubMedPubMedCentral
8.
Niknam Z, Hosseinzadeh F, Shams F, Fath-Bayati L, Nuoroozi G, Mohammadi Amirabad L, et al. Recent advances and challenges in graphene‐based nanocomposite scaffolds for tissue engineering application. J Biomedical Mater Res Part A. 2022;110(10):1695–721.CrossRef
9.
Lin JT, Lane JM. Osteoporosis: a review. Clin Orthop Relat Research®. 2004;425:126–34.CrossRef
10.
11.
12.
Paspaliaris V, Kolios G. Stem cells in osteoporosis: from biology to new therapeutic approaches. Stem Cells International. 2019;2019.
13.
Hadjiargyrou M, Komatsu DE. The therapeutic potential of microRNAs as orthobiologics for skeletal fractures. J Bone Miner Res. 2019;34(5):797–809.PubMedCrossRef
14.
Liu H, Hao D, Wang X, Hu H, Li Y, Dong X. MiR-30a-3p promotes ovariectomy-induced osteoporosis in rats via targeting SFRP1. Eur Rev Med Pharmacol Sci. 2019;23(22):9754–60.PubMed
15.
Nilsson A, Sundh D, Bäckhed F, Lorentzon M. Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double‐blind, clinical trial. J Intern Med. 2018;284(3):307–17.PubMedCrossRef
16.
Kunes M, Kvetina J, Probiotics. Preclinical testing for Verification of their gastrointestinal effectiveness. Nutraceuticals: Elsevier; 2016. pp. 799–810.
17.
18.
Britton RA, Irwin R, Quach D, Schaefer L, Zhang J, Lee T, et al. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol. 2014;229(11):1822–30.PubMedPubMedCentralCrossRef
19.
McCabe LR, Irwin R, Schaefer L, Britton RA. Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol. 2013;228(8):1793–8.PubMedPubMedCentralCrossRef
20.
Tripathy N, Perumal E, Ahmad R, Song JE, Khang G. Hybrid composite biomaterials. Principles of Regenerative Medicine. Elsevier; 2019. pp. 695–714.
21.
Huang S, Chen JC, Hsu CW, Chang WH. Effects of nano calcium carbonate and nano calcium citrate on toxicity in ICR mice and on bone mineral density in an ovariectomized mice model. Nanotechnology. 2009;20(37):375102.PubMedCrossRef
22.
Fookes FA, Mengatto LN, Rigalli A, Luna JA. Controlled fluoride release for osteoporosis treatment using orally administered chitosan hydrogels. J Drug Deliv Sci Technol. 2019;51:268–75.CrossRef
23.
Riggs BL, Seeman E, Hodgson SF, Taves DR, O’Fallon WM. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis: comparison with conventional therapy. N Engl J Med. 1982;306(8):446–50.PubMedCrossRef
24.
Clark JD, Gebhart GF, Gonder JC, Keeling ME, Kohn DF. The 1996 guide for the care and use of laboratory animals. ILAR J. 1997;38(1):41–8.PubMedCrossRef
25.
Montazeri-Najafabady N, Ghasemi Y, Dabbaghmanesh MH, Ashoori Y, Talezadeh P, Koohpeyma F, et al. Exploring the bone sparing effects of postbiotics in the post-menopausal rat model. BMC Complement Med Ther. 2021;21(1):155.PubMedPubMedCentralCrossRef
26.
Montazeri-Najafabady N, Ghasemi Y, Dabbaghmanesh MH, Talezadeh P, Koohpeyma F, Gholami A. Supportive role of probiotic strains in protecting rats from ovariectomy-induced cortical bone loss. Probiotics and Antimicrobial Proteins. 2019;11:1145–54.PubMedCrossRef
27.
Bala WA, Benitha V, Jeyasubramanian K, Hikku G, Sankar P, Kumar SV. Investigation of anti-bacterial activity and cytotoxicity of calcium fluoride nanoparticles. J Fluorine Chem. 2017;193:38–44.CrossRef
28.
Nakhaei O, Shahtahmassebi N, Rezaeeroknabadi M, Mohagheghi MB. Synthesis, characterization and study of optical properties of polyvinyl alcohol/CaF2 nanocomposite films. Scientia Iranica. 2012;19(6):1979–83.CrossRef
29.
Park SB, Lee YJ, Chung CK. Bone mineral density changes after ovariectomy in rats as an osteopenic model: stepwise description of double dorso-lateral approach. J Korean Neurosurg Soc. 2010;48(4):309.PubMedPubMedCentralCrossRef
30.
Chargui I, Grissa I, Bensassi F, Hrira MY, Haouem S, Haouas Z, et al. Oxidative stress, biochemical and histopathological alterations in the liver and kidney of female rats exposed to low doses of deltamethrin (DM): a molecular assessment. Biomed Environ Sci. 2012;25(6):672–83.PubMed
31.
Lepola V, Jalovaara P, Väänänen K. The influence of clodronate on the torsional strength of the growing rat tibia in immobilization osteoporosis. Bone. 1994;15(3):367–71.PubMedCrossRef
32.
Tahvildari K, ESMAEILI PM, Ghammamy S, Nabipour H. CaF2 nanoparticles: synthesis and characterization. 2012.
33.
Alharbi ND. Size controlled CaF2 nanocubes and their dosimetric properties using photoluminescence technique. Journal of Nanomaterials. 2015;2015.
34.
Collins FL, Rios-Arce ND, Schepper JD, Jones AD, Schaefer L, Britton RA, et al. Beneficial effects of Lactobacillus reuteri 6475 on bone density in male mice is dependent on lymphocytes. Sci Rep. 2019;9(1):1–17.CrossRef
35.
Collins FL, Irwin R, Bierhalter H, Schepper J, Britton RA, Parameswaran N, et al. Lactobacillus reuteri 6475 increases bone density in intact females only under an inflammatory setting. PLoS ONE. 2016;11(4):e0153180.PubMedPubMedCentralCrossRef
36.
Azami M, Jalilifiroozinezhad S, Mozafari M, Rabiee M. Synthesis and solubility of calcium fluoride/hydroxy-fluorapatite nanocrystals for dental applications. Ceram Int. 2011;37(6):2007–14.CrossRef
37.
Spencer H, Kramer L. Osteoporosis: calcium, fluoride, and aluminum interactions. J Am Coll Nutr. 1985;4(1):121–8.PubMedCrossRef
38.
Mustafa RA, Alfky NA, Hijazi HH, Header EA, Azzeh FS. Biological effect of calcium and vitamin D dietary supplements against osteoporosis in ovariectomized rats. Prog Nutr. 2018;20(1):86–93.
39.
Parvaneh K, Jamaluddin R, Karimi G, Erfani R. Effect of probiotics supplementation on bone mineral content and bone mass density. Sci World J. 2014;2014.
40.
Ji M-X, Yu Q. Primary osteoporosis in postmenopausal women. Chronic Dis Translational Med. 2015;1(01):9–13.CrossRef
41.
Chen KLA, Liu X, Zhao YC, Hieronymi K, Rossi G, Auvil LS, et al. Long-term administration of conjugated estrogen and bazedoxifene decreased murine fecal β-glucuronidase activity without impacting overall microbiome community. Sci Rep. 2018;8(1):1–11.
42.
Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Translational Med. 2012;10(1):1–11.CrossRef
43.
Sinkiewicz G. Lactobacillus reuteri in Health and Disease. Malmö University; 2010.
44.
Mao H, Wang W, Shi L, Chen C, Han C, Zhao J, et al. Metabolomics and physiological analysis of the effect of calcium supplements on reducing bone loss in ovariectomized rats by increasing estradiol levels. Nutr Metabolism. 2021;18(1):1–14.CrossRef
45.
Suganthan N, Kumanan T, Kesavan V, Aravinthan M, Rajeshkannan N. Vitamin D status among postmenopausal osteoporotic women: a hospital based cross-sectional study from Northern Sri Lanka. BMC Nutr. 2020;6(1):1–8.CrossRef
46.
Jones ML, Martoni CJ, Prakash S. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial. J Clin Endocrinol Metabolism. 2013;98(7):2944–51.CrossRef
47.
Gokhale S, Bhaduri A. Provitamin D3 modulation through prebiotics supplementation: simulation based assessment. Sci Rep. 2019;9(1):1–8.CrossRef
48.
Berlin T, Björkhem I. Effect of calcium intake on serum levels of 25-hydroxyvitamin D3. Eur J Clin Invest. 1988;18(1):52–5.PubMedCrossRef
49.
Jorde R, Grimnes G. Increased calcium intake is associated lower serum 25-hydroxyvitamin D levels in subjects with adequate vitamin D intake: a population-based observational study. BMC Nutr. 2020;6(1):1–9.CrossRef
50.
Kalu DN, Chen C. Ovariectomized murine model of postmenopausal calcium malabsorption. J Bone Miner Res. 1999;14(4):593–601.PubMedCrossRef
51.
Ghanem K, Badawy I, Abdel-Salam A. Influence of yoghurt and probiotic yoghurt on the absorption of calcium, magnesium, iron and bone mineralization in rats. Milchwissenschaft. 2004;59(9–10):472–5.
52.
Stamp TC, Jenkins MV, Loveridge N, Saphier PW, Katakity M, MacArthur SE. Fluoride therapy in osteoporosis: Acute effects on parathyroid and mineral homoeostasis. Clin Sci. 1988;75(2):143–6.CrossRef
53.
Fočak M, Hasković E, Suljević D. The effect of fluoride on the serum level of calcium in the rat (Rattus norvegicus). Archives of Biological Sciences. 2012;64(4):1585–9.CrossRef
54.
Azinge E, Bolarin D. Osteocalcin and bone-specific alkaline phosphatase in sickle cell haemoglobinopathies. Nigerian J Physiological Sci. 2006;21:1–2.
55.
Hooshmand S, Chai SC, Saadat RL, Payton ME, Brummel-Smith K, Arjmandi BH. Comparative effects of dried plum and dried apple on bone in postmenopausal women. Br J Nutr. 2011;106(6):923–30.PubMedCrossRef
56.
Wang J, Pei F, Tu C, Zhang H, Qiu X. Serum bone turnover markers in patients with primary bone tumors. Oncology. 2007;72(5–6):338–42.PubMedCrossRef
57.
Grigoryan AV, Dimitrova AA, Kostov KG, Russeva AL, Atanasova MA, Blagev AB, et al. Changes of serum concentrations of alkaline phosphatase and metalloproteinase-9 in an ovariectomized wistar rat model of osteoporosis. J Biomedical Clin Res. 2017;10(1):32–6.CrossRef
58.
Kim SK, Lee MH, Rhee MH. Studies on the effects of biomedicinal agents on serum concentration of Ca2+, P and ALP activity in osteoporosis-induced rats. J Vet Sci. 2003;4(2):151–4.PubMedCrossRef
59.
Jafarnejad S, Djafarian K, Fazeli MR, Yekaninejad MS, Rostamian A, Keshavarz SA. Effects of a multispecies probiotic supplement on bone health in osteopenic postmenopausal women: a randomized, double-blind, controlled trial. J Am Coll Nutr. 2017;36(7):497–506.PubMedCrossRef
Metadata
Title
The beneficial effects of simultaneous supplementation of Lactobacillus reuteri and calcium fluoride nanoparticles on ovariectomy-induced osteoporosis
Authors
Dibachehr Rahmani
Bahareh Faal
Hakimeh Zali
Saeed Hesami Tackallou
Zahra Niknam
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-04167-6

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue

Research

Effect of Oroxylum indicum on hepatocellular carcinoma via the P53 and VEGF pathways based on microfluidic chips

Research

Melittin as a safe compound to BALB/c mice immune system; a tiered approach immunotoxicity screening

Research

Antibacterial potential of biosynthesized silver nanoparticles using Nepeta sessilifolia Bunge and Salvia hydrangea DC. ex Benth. extracts from the natural habitats of Iran's Rangelands

Research

Isolation and identification of active ingredients and biological activity of Dioscorea nipponica Makino

Retraction Note

Retraction Note: The traditional tibetan medicine Yukyung Karne exhibits a potent anti-metastatic activity by inhibiting the epithelial to mesenchymal transition and cell migration

Research

Berberine improves inhibitory avoidance memory impairment of Toxoplasma gondii-infected rat model of ketamine-induced schizophrenia